MCI's total commitment to male contraception now exceeds $3M USD since 2017
DURHAM, N.C. - ncarol.com -- Male Contraceptive Initiative (MCI), a private non-profit foundation, announced four grants, including a grant to Eppin Pharma Inc to support research and development of a male contraceptive, raising MCI's total commitment to male contraception to over $3M USD since 2017.
Eppin Pharma will receive $300,000 to aid in their work developing a novel form of male contraception. Eppin Pharma's product, EP055, is a hormone-free method of contraception that is quickly moving to first-in-human studies. EP055 inhibits sperm motility that is crucial for fertility. The drug is intended to be administered as a pill to men on a daily or on-demand basis, providing protection from pregnancy.
With over $3 million invested in male contraceptive product development, MCI seeks to push male contraceptive research projects towards commercialization. There are a variety of male contraceptive research projects in the drug development pipeline; from early stage screening of drugs to studies that pave the way for early clinical trials, and consistent with their mission, MCI focuses their funding on promising projects within this pipeline like Eppin Pharma's EP055. MCI's mission is to facilitate research and development of male contraceptives for people around the world, and to build awareness among researchers, donors and the general public about the demand for and status of novel male contraceptive methods.
More on ncarol.com
Through its funding efforts, MCI has championed this mission in manifold ways: investing in promising product development through this and other rounds of funding, supporting students and young professionals through fellowships and travel grants, and consistently advocating with the public and media for an increased method mix that includes male contraception.
"More and more men are expressing the desire to participate in contraception with their partners. We are confident that the time is right to emphatically get behind the talent and energy in the field in order to achieve a real vision for a shared contraceptive future," said MCI Executive Director Heather Vahdat.
Dr. Michael O'Rand, CEO and Co-Founder of Eppin added – "We are grateful for the support that MCI has given us and hopeful that this investment in our technology will advance the field of male non-hormonal contraception."
https://www.malecontraceptive.org/
Eppin Pharma will receive $300,000 to aid in their work developing a novel form of male contraception. Eppin Pharma's product, EP055, is a hormone-free method of contraception that is quickly moving to first-in-human studies. EP055 inhibits sperm motility that is crucial for fertility. The drug is intended to be administered as a pill to men on a daily or on-demand basis, providing protection from pregnancy.
With over $3 million invested in male contraceptive product development, MCI seeks to push male contraceptive research projects towards commercialization. There are a variety of male contraceptive research projects in the drug development pipeline; from early stage screening of drugs to studies that pave the way for early clinical trials, and consistent with their mission, MCI focuses their funding on promising projects within this pipeline like Eppin Pharma's EP055. MCI's mission is to facilitate research and development of male contraceptives for people around the world, and to build awareness among researchers, donors and the general public about the demand for and status of novel male contraceptive methods.
More on ncarol.com
- Peachtree Immediate Care Adjusting to Changing Patient Needs in Response to Coronavirus Pandemic
- Permian Museum Spring Fossil Egg Hunt Photos
- Elevated Resources Identified as Value Leader for Nimble and Turn-key Personas in Spend Matters' Temp Staffing Solution Map
- Thiel College Admissions Office announces virtual visits and waiving test scores for applicants
- Updates On Families First Coronavirus Response Act
Through its funding efforts, MCI has championed this mission in manifold ways: investing in promising product development through this and other rounds of funding, supporting students and young professionals through fellowships and travel grants, and consistently advocating with the public and media for an increased method mix that includes male contraception.
"More and more men are expressing the desire to participate in contraception with their partners. We are confident that the time is right to emphatically get behind the talent and energy in the field in order to achieve a real vision for a shared contraceptive future," said MCI Executive Director Heather Vahdat.
Dr. Michael O'Rand, CEO and Co-Founder of Eppin added – "We are grateful for the support that MCI has given us and hopeful that this investment in our technology will advance the field of male non-hormonal contraception."
https://www.malecontraceptive.org/
Source: Male Contraceptive Initiative
Filed Under: Health
0 Comments
Latest on ncarol.com
- Generis Knowledge Management Join Gens and Associates Premier Benchmark Membership Program
- Labratfinder.com launches the COVID-19 web research info center as "Who is Who, Where is Who, and Who Uses What Products" free to access web page
- Charlotte's Oldest Non-profit Arts Organization And Gallery Gets Creative To Support Local Artists
- FEMA Approves North Carolina Request to Stand Up Shelters That Follow Social Distance Guidelines
- GrooveCar Direct Announces 10 New Credit Union Partnerships in Q1 2020
- Alpega TMS brings together the expertise of inet and transwide
- McGuire Group Facilities Donating N95 Respirator Masks to First Responders
- Announcing the Spring 2020 Opening of TOKYO mizumachi and SUMIDA RIVER WALK Footbridge, Connecting Tokyo SKYTREE® to Asakusa area sites
- North Carolina: Governor Cooper Orders Flexibility in Law Enforcement Training and Certification
- Pvilion Awarded Air Force SBIR Phase II Program For Rapidly Deployable, Solar Powered Structures
- Helping aspiring authors turn coronavirus self-isolation into opportunity
- Fintech Working to Help Hospitals Ease COVID-19 Financial Burden
- Refereum, DLive, Tron, and Bittorrent Team Together to Reward Users for Social Distancing During COVID-19
- Ideanomics' Announces Pilot Program to Monetize EV Energy Sales
- Culture of innovation and creativity makes SAS a Best Workplace in Asia
- Higher Digital Appoints New Advisory Board Members as Colleges and Universities Seek Guidance to Adapt to Online Teaching and Learning
- Chicago Tech Startup Launches New "House Painting In Place" Technology In Wake Of Coronavirus (COVID-19) Pandemic
- Abintegro redefines how employers recruit early talent
- NOKR Urges Preparedness During COVID-19 Global Emergency
- Datavalet Helps Teams Work Remotely During Covid-19 Crisis